Specific risk factors for RA-ILD include positive anti-cyclic citrullinated peptide antibodies or IgM rheumatoid factor, MUC5b polymorphisms, and, in some studies, RA disease activity [41, 42]. This evidence concerns the gene MUC5B and rheumatoid arthritis.